Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017

Publisher Name :
Date: 10-Nov-2017
No. of pages: 104
Inquire Before Buying

In this report, the global Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Glucagon Like Peptide-1 (GLP-1) Agonists in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Glucagon Like Peptide-1 (GLP-1) Agonists market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- Novo Nordisk

- AstraZeneca

- Eli Lily

- GSK

- Sanofi

- Bristol-Myers Squibb

- Amylin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Exenatied

- Liraglutide

- Lixisenatide

- Abliglutide

- Dulaglutide

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Hospital

- Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017

Table of Contents
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017
1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type (Product Category)
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Type (Product Category) in 2016
1.2.3 Exenatied
1.2.4 Liraglutide
1.2.5 Lixisenatide
1.2.6 Abliglutide
1.2.7 Dulaglutide
1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
1.3.1 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region (2012-2022)
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Glucagon Like Peptide-1 (GLP-1) Agonists (2012-2022)
1.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Status and Outlook (2012-2022)
1.5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production Status and Outlook (2012-2022)
2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Competition by Manufacturers
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Share by Manufacturers (2012-2017)
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Manufacturers (2012-2017)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Sales Area and Product Type
2.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
2.5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate
2.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Market Share by Region (2012-2017)
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Market Share by Region (2012-2017)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Region (2012-2017)
4.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2012-2017)
4.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2012-2017)
4.4 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2012-2017)
4.5 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2012-2017)
4.7 India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2012-2017)
5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue (Value), Price Trend by Type
5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Market Share by Type (2012-2017)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2012-2017)
5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2012-2017)
5.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth by Type (2012-2017)
6 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis by Application
6.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Market Share by Application (2012-2017)
6.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Profiles/Analysis
7.1 Novo Nordisk
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 AstraZeneca
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Eli Lily
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 GSK
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Sanofi
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Bristol-Myers Squibb
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Amylin
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
8 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Cost Analysis
8.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast (2017-2022)
12.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price and Trend Forecast (2017-2022)
12.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Exenatied
Table Major Manufacturers of Exenatied
Figure Product Picture of Liraglutide
Table Major Manufacturers of Liraglutide
Figure Product Picture of Lixisenatide
Table Major Manufacturers of Lixisenatide
Figure Product Picture of Abliglutide
Table Major Manufacturers of Abliglutide
Figure Product Picture of Dulaglutide
Table Major Manufacturers of Dulaglutide
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) by Applications (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Players Product Capacity (K Units) (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) of Key Manufacturers in 2016
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) of Key Manufacturers in 2017
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Players Product Production (K Units) (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) of Key Manufacturers (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers (2012-2017)
Figure 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers
Figure 2017 Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Players Product Revenue (Million USD) (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table 2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Sales Area
Table Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Category
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 Manufacturers
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 5 Manufacturers
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share by Region (2012-2017)
Figure 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share by Region
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Region (2012-2017)
Figure 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Region
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Region (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2012-2017)
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Market by Region (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Region (2012-2017)
Figure 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Market Share by Region
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) by Type (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Type (2012-2017)
Figure Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2012-2017)
Figure 2016 Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Type (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2012-2017)
Figure 2016 Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Type (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth by Type (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) by Application (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Applications (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2016
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2012-2017)
Table Eli Lily Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2012-2017)
Table Amylin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Distributors/Traders List
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (Million USD) and Trend Forecast (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) Forecast by Region (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share Forecast by Region (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share Forecast by Region (2017-2022)
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) Forecast by Type (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) Forecast by Type (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Type (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • United States Diabetes Drugs Market Report 2017
    Published: 15-Nov-2017        Price: US 3800 Onwards        Pages: 124
    In this report, the United States Diabetes Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of D......
  • Global Insulin Market Research Report 2017
    Published: 13-Nov-2017        Price: US 2900 Onwards        Pages: 108
    In this report, the global Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Insulin in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Sout......
  • United States Glucagon Market Report 2017
    Published: 13-Nov-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Glucagon market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Glucago......
  • United States Lixisenatide Market Report 2017
    Published: 13-Nov-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States Lixisenatide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Lix......
  • Global Diabetes Drugs Sales Market Report 2017
    Published: 10-Nov-2017        Price: US 4000 Onwards        Pages: 128
    In this report, the global Diabetes Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan ......
  • Global Glucagon Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 10-Nov-2017        Price: US 3480 Onwards        Pages: 117
    Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release s......
  • Global Liraglutide Market Professional Survey Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 100
    This report studies Liraglutide in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - HEC Pharm - Teva - Bachem - Bharat Pharmaceuticals - Kingpep Biot......
  • United States Antidiabetic Biguanides Market Report 2017
    Published: 09-Nov-2017        Price: US 3800 Onwards        Pages: 113
    In this report, the United States Antidiabetic Biguanides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and......
  • United States Antidiabetic SGLT-2 Inhibitor Market Report 2017
    Published: 09-Nov-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Antidiabetic SGLT-2 Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market sha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs